SEC Form 4
HealthEquity, Inc (HQY) insider trading
In the 12 months to Oct 24, 2026, 6 HQY insiders reported open-market sales of $4.2M across 11 filings; one EVP chief prod & strat officer bought $11.9K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $4.2M
- 11 filings · 6 insiders
- Open-market purchases
- $11.9K
- 1 filing · Sunil Rajasekar, EVP Chief Prod & Strat Officer
- Pre-arranged sales (10b5-1)
- 8 of 11
- $2.7M of $4.2M sold (65%)
Who traded HQY, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
HQY daily close from Oct 24, 2025 to Oct 23, 2026, between $73.21 and $106.79, last $103.97. 11 sale and 1 purchase filings by 6 insiders, marked at their filing dates. Elimelech Rosner, EVP, CHIEF TECHNOLOGY OFFICER: sold $1.0M across 1 filing, first filed Dec 19, 2025, last Dec 19, 2025. Delano Ladd, EVP, General Counsel: sold $973.9K across 3 filings, first filed Nov 24, 2025, last Jun 1, 2026. Adrian T. Dillon, Director: sold $798.4K across 1 filing, first filed Aug 27, 2026, last Aug 27, 2026. Michael Henry Fiore, EVP, CHIEF COMMERCIAL OFFICER: sold $756.8K across 3 filings, first filed Jun 2, 2026, last Jul 14, 2026. Gayle Furgurson Wellborn, Director: sold $644.8K across 2 filings, first filed Dec 16, 2025, last Jun 1, 2026. Sunil Rajasekar, EVP Chief Prod & Strat Officer: sold $13.3K and bought $11.9K across 2 filings, first filed Oct 19, 2026, last Oct 19, 2026.
Largest mark · tap a row for others
Elimelech Rosner · EVP, CHIEF TECHNOLOGY OFFICER
Sale $1,046,090
10,959 shares at $95.45 avg
Filed Dec 19, 2025 · traded Dec 18
Close on filing date $95.50
Elimelech Rosner · EVP, CHIEF TECHNOLOGY OFFICER
EVP, CHIEF TECHNOLOGY OFFICER
$1.0M soldDelano Ladd · EVP, General Counsel
EVP, General Counsel
$973.9K soldAdrian T. Dillon · Director
Director
$798.4K soldMichael Henry Fiore · EVP, CHIEF COMMERCIAL OFFICER
EVP, CHIEF COMMERCIAL OFFICER
$756.8K soldGayle Furgurson Wellborn · Director
Director
$644.8K soldSunil Rajasekar · EVP Chief Prod & Strat Officer
EVP Chief Prod & Strat Officer
$13.3K sold$11.9K boughtHas HealthEquity, Inc's CEO sold stock?
No. Scott Cutler (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
12 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Elimelech Rosner | EVP, CHIEF TECHNOLOGY OFFICER | $1.0M | — | 1 | — | |
| Delano Ladd | EVP, General Counsel | $973.9K | — | 3 | 100% of sales | |
| Adrian T. Dillon | Director | $798.4K | — | 1 | 100% of sales | |
| Michael Henry Fiore | EVP, CHIEF COMMERCIAL OFFICER | $756.8K | — | 3 | 100% of sales | |
| Gayle Furgurson Wellborn | Director | $644.8K | — | 2 | 34% of sales | |
| Sunil Rajasekar | EVP Chief Prod & Strat Officer | $13.3K | $11.9K | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Sunil Rajasekar EVP Chief Prod & Strat Officer | Purchase | 131 | $91.16 | $11.9K | 53,405 | |
traded | Sunil Rajasekar EVP Chief Prod & Strat Officer | Sale | 131 | $101.60 | $13.3K | 53,297 | |
traded | Adrian T. Dillon Director | SalePre-arranged (10b5-1) | 7,632 | $104.61 | $798.4K | 63,727 | |
traded | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | SalePre-arranged (10b5-1) | 2,354 | $95.00 | $223.6K | 52,244 | |
traded | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | SalePre-arranged (10b5-1) | 2,470 | $95.00 | $234.7K | 56,643 | |
traded | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | SalePre-arranged (10b5-1) | 3,142 | $95.00 | $298.5K | 59,113 | |
traded | Delano Ladd EVP, General Counsel | SalePre-arranged (10b5-1) | 7,500 | $90.00 | $675.0K | 91,141 | |
traded | Gayle Furgurson Wellborn Director | SalePre-arranged (10b5-1) | 2,439 | $90.00 | $219.5K | 19,733 | |
traded | Delano Ladd EVP, General Counsel | SalePre-arranged (10b5-1) | 1,500 | $94.72 | $142.1K | 73,979 | |
traded | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | Sale | 10,959 | $95.45 | $1.0M | 45,742 | |
traded | Gayle Furgurson Wellborn Director | Sale | 4,339 | $98.03 | $425.3K | 19,733 | |
traded | Delano Ladd EVP, General Counsel | SalePre-arranged (10b5-1) | 1,500 | $104.56 | $156.8K | 75,479 |
GET /stocks/filings/vX/form-4?tickers=HQY&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HQY"
],
"issuer_cik": "0001428336",
"owner_cik": "0001934884",
"accession_number": "0001934884-26-000007",
"form_type": "4",
"filing_date": "2026-10-19",
"period_of_report": "2026-04-22",
"issuer_name": "HEALTHEQUITY, INC.",
"issuer_trading_symbol": "HQY",
"owner_name": "Rajasekar Sunil",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP Chief Prod & Strat Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-08",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 23,
"transaction_price_per_share": 95.06,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 53405,
"transaction_value": 2186.38,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F4",
"description": "Represents shares delivered to cover the previous short sale."
},
{
"id": "F2",
"description": "The transactions reported were executed in broker-managed discretionary accounts without the reporting person's knowledge. The reporting of these transactions was untimely because the reporting person did not become aware of the transactions at the time they occurred."
},
{
"id": "F3",
"description": "The reporting person has voluntarily paid to the issuer a de minimis amount (approximately $1,650), which represent all \"profits\" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the transactions reported herein."
}
],
"remarks": "The Power of Attorney given by Mr. Rajasekar was previously filed with the U.S. Securities and Exchange Commission on May 12, 2026 as an exhibit to a statement on Form 3 filed by Mr. Rajasekar with respect to HealthEquity, Inc. and is hereby incorporated by reference."
},
{
"tickers": [
"HQY"
],
"issuer_cik": "0001428336",
"owner_cik": "0001934884",
"accession_number": "0001934884-26-000007",
"form_type": "4",
"filing_date": "2026-10-19",
"period_of_report": "2026-04-22",
"issuer_name": "HEALTHEQUITY, INC.",
"issuer_trading_symbol": "HQY",
"owner_name": "Rajasekar Sunil",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP Chief Prod & Strat Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-15",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 108,
"transaction_price_per_share": 90.33,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 53405,
"transaction_value": 9755.64,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F4",
"description": "Represents shares delivered to cover the previous short sale."
},
{
"id": "F3",
"description": "The reporting person has voluntarily paid to the issuer a de minimis amount (approximately $1,650), which represent all \"profits\" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the transactions reported herein."
}
],
"remarks": "The Power of Attorney given by Mr. Rajasekar was previously filed with the U.S. Securities and Exchange Commission on May 12, 2026 as an exhibit to a statement on Form 3 filed by Mr. Rajasekar with respect to HealthEquity, Inc. and is hereby incorporated by reference."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 54 records
- Option exercises3 records
- Tax withholding27 records
- Grants and awards20 records
- Gifts4 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HQY every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.